Malignancy‐related causes of death in human immunodeficiency virus‐infected patients in the era of highly active antiretroviral therapy
暂无分享,去创建一个
[1] G. Byrnes,et al. Screening for lung cancer. , 2004, The Cochrane database of systematic reviews.
[2] K. Fearon,et al. Reduced total energy expenditure and physical activity in cachectic patients with pancreatic cancer can be modulated by an energy and protein dense oral supplement enriched with n-3 fatty acids , 2004, British Journal of Cancer.
[3] D. Costagliola,et al. Incidence of non-AIDS-defining cancers before and during the highly active antiretroviral therapy era in a cohort of human immunodeficiency virus-infected patients. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[4] Y. Nishiwaki,et al. Daily omega-3 fatty acid intake and depression in Japanese patients with newly diagnosed lung cancer , 2004, British Journal of Cancer.
[5] M. Muscaritoli,et al. Phase II study of high‐dose fish oil capsules for patients with cancer‐related cachexia , 2005, Cancer.
[6] S. Gabriel,et al. EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy , 2004, Science.
[7] M. Peet. Eicosapentaenoic acid in the treatment of schizophrenia and depression: rationale and preliminary double-blind clinical trial results. , 2003, Prostaglandins, leukotrienes, and essential fatty acids.
[8] P. Morlat,et al. Malignancy-related causes of death in human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy. , 2005, Cancer.
[9] D. Serraino,et al. Lung carcinoma in 36 patients with human immunodeficiency virus infection , 2000, Cancer.